{
    "2018-05-07": [
        [
            {
                "time": "2018-04-25",
                "original_text": "How Amgen’s Enbrel and Neulasta Performed in 1Q18",
                "features": {
                    "keywords": [
                        "Amgen",
                        "Enbrel",
                        "Neulasta",
                        "1Q18",
                        "performance"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "biotech"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-03-15",
                "original_text": "Taltz: Therapy for Psoriasis Indication",
                "features": {
                    "keywords": [
                        "Taltz",
                        "psoriasis",
                        "therapy",
                        "indication"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-05-03",
                "original_text": "Allergan’s US General Medicines Segment in 1Q18",
                "features": {
                    "keywords": [
                        "Allergan",
                        "US",
                        "General Medicines",
                        "segment",
                        "1Q18"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            }
        ]
    ]
}